Ming Shi

PD‐1 and PD‐L1 upregulation promotes CD8⁺ T‐cell apoptosis and postoperative recurrence in hepatocellular carcinoma patients

Feng Shi, Ming Shi, Zhen Zeng et al. · International Journal of Cancer · 2010 · 460 citations

Medicine, Immunology, Oncology +17

A combination of humanised anti-CD19 and anti-BCMA CAR T cells in patients with relapsed or refractory multiple myeloma: a single-arm, phase 2 trial

Zhiling Yan, Jiang Cao, Hai Cheng et al. · The Lancet Haematology · 2019 · 317 citations

Life Sciences, Hematology, Immunology +16

Stat3-coordinated Lin-28–let-7–HMGA2 and miR-200–ZEB1 circuits initiate and maintain oncostatin M-driven epithelial–mesenchymal transition

Liang Guo, C Chen, Ming Shi et al. · Oncogene · 2013 · 211 citations · Full text

Medicine, Molecular Biology, Oncology +17

Potent anti‐leukemia activities of humanized CD19‐targeted Chimeric antigen receptor T (CAR‐T) cells in patients with relapsed/refractory acute lymphoblastic leukemia

Jiang Cao, Gang Wang, Hai Cheng et al. · American Journal of Hematology · 2018 · 174 citations · Full text

Life Sciences, Immunology, Oncology +17

A microRNA-inducible CRISPR–Cas9 platform serves as a microRNA sensor and cell-type-specific genome regulation tool

Xiwen Wang, Lu‐Feng Hu, Jing Hao et al. · Nature Cell Biology · 2019 · 161 citations

Life Sciences, Genetics, Molecular Biology +14